Literature DB >> 24661777

Reprogramming antitumor immunity.

Joseph G Crompton1, David Clever2, Raul Vizcardo3, Mahendra Rao4, Nicholas P Restifo5.   

Abstract

Regenerative medicine holds great promise in replacing tissues and organs lost to degenerative disease and injury. Application of the principles of cellular reprogramming for the treatment of cancer, however, is not well established. Here, we present an overview of cellular reprogramming techniques used in regenerative medicine, and within this context, envision how the scope of regenerative medicine may be expanded to treat metastatic cancer by revitalizing an exhausted and senescent immune system. Published by Elsevier Ltd.

Entities:  

Keywords:  T cell reprogramming; cancer immunotherapy; regenerative medicine

Mesh：

Year:  2014        PMID： 24661777      PMCID： PMC4373650          DOI： 10.1016/j.it.2014.02.003

Source DB:  PubMed          Journal:  Trends Immunol        ISSN： 1471-4906            Impact factor:   16.687


  93 in total

1.  Heart regeneration in zebrafish.

Authors:  Kenneth D Poss; Lindsay G Wilson; Mark T Keating
Journal:  Science       Date:  2002-12-13       Impact factor: 47.728

2.  Activation of Notch signaling pathway precedes heart regeneration in zebrafish.

Authors:  Angel Raya; Christopher M Koth; Dirk Büscher; Yasuhiko Kawakami; Tohru Itoh; R Marina Raya; Gabriel Sternik; Huai-Jen Tsai; Concepción Rodríguez-Esteban; Juan Carlos Izpisúa-Belmonte
Journal:  Proc Natl Acad Sci U S A       Date:  2003-08-08       Impact factor: 11.205

3.  Stepwise reprogramming of B cells into macrophages.

Authors:  Huafeng Xie; Min Ye; Ru Feng; Thomas Graf
Journal:  Cell       Date:  2004-05-28       Impact factor: 41.582

4.  Viable offspring derived from fetal and adult mammalian cells.

Authors:  I Wilmut; A E Schnieke; J McWhir; A J Kind; K H Campbell
Journal:  Nature       Date:  1997-02-27       Impact factor: 49.962

5.  Stimulus-triggered fate conversion of somatic cells into pluripotency.

Authors:  Haruko Obokata; Teruhiko Wakayama; Yoshiki Sasai; Koji Kojima; Martin P Vacanti; Hitoshi Niwa; Masayuki Yamato; Charles A Vacanti
Journal:  Nature       Date:  2014-01-30       Impact factor: 49.962

6.  Viral persistence alters CD8 T-cell immunodominance and tissue distribution and results in distinct stages of functional impairment.

Authors:  E John Wherry; Joseph N Blattman; Kaja Murali-Krishna; Robbert van der Most; Rafi Ahmed
Journal:  J Virol       Date:  2003-04       Impact factor: 5.103

Review 7.  Tolerance and exhaustion: defining mechanisms of T cell dysfunction.

Authors:  Andrea Schietinger; Philip D Greenberg
Journal:  Trends Immunol       Date:  2013-11-06       Impact factor: 16.687

8.  Human proT-cells generated in vitro facilitate hematopoietic stem cell-derived T-lymphopoiesis in vivo and restore thymic architecture.

Authors:  Génève Awong; Jastaranpreet Singh; Mahmood Mohtashami; Maria Malm; Ross N La Motte-Mohs; Patricia M Benveniste; Pablo Serra; Elaine Herer; Marcel R van den Brink; Juan Carlos Zúñiga-Pflücker
Journal:  Blood       Date:  2013-11-08       Impact factor: 22.113

Review 9.  Central memory and effector memory T cell subsets: function, generation, and maintenance.

Authors:  Federica Sallusto; Jens Geginat; Antonio Lanzavecchia
Journal:  Annu Rev Immunol       Date:  2004       Impact factor: 28.527

10.  Pro-inflammatory human Th17 cells selectively express P-glycoprotein and are refractory to glucocorticoids.

Authors:  Radha Ramesh; Lina Kozhaya; Kelly McKevitt; Ivana M Djuretic; Thaddeus J Carlson; Maria A Quintero; Jacob L McCauley; Maria T Abreu; Derya Unutmaz; Mark S Sundrud
Journal:  J Exp Med       Date:  2014-01-06       Impact factor: 14.307
View more
  23 in total

1.  A Three-dimensional Thymic Culture System to Generate Murine Induced Pluripotent Stem Cell-derived Tumor Antigen-specific Thymic Emigrants.

Authors:  Raul Vizcardo; S M Rafiqul Islam; Takuya Maeda; Naritaka Tamaoki; Meghan L Good; Nicholas D Klemen; Marta Bosch-Marce; Li Jia; Mikhael J Kruhlak; Nicholas P Restifo
Journal:  J Vis Exp       Date:  2019-08-09       Impact factor: 1.355

Review 2.  T cell exhaustion during persistent viral infections.

Authors:  Shannon M Kahan; E John Wherry; Allan J Zajac
Journal:  Virology       Date:  2015-01-22       Impact factor: 3.616

3.  CD38-NAD+Axis Regulates Immunotherapeutic Anti-Tumor T Cell Response.

Authors:  Shilpak Chatterjee; Anusara Daenthanasanmak; Paramita Chakraborty; Megan W Wyatt; Payal Dhar; Shanmugam Panneer Selvam; Jianing Fu; Jinyu Zhang; Hung Nguyen; Inhong Kang; Kyle Toth; Mazen Al-Homrani; Mahvash Husain; Gyda Beeson; Lauren Ball; Kristi Helke; Shahid Husain; Elizabeth Garrett-Mayer; Gary Hardiman; Meenal Mehrotra; Michael I Nishimura; Craig C Beeson; Melanie Gubbels Bupp; Jennifer Wu; Besim Ogretmen; Chrystal M Paulos; Jeffery Rathmell; Xue-Zhong Yu; Shikhar Mehrotra
Journal:  Cell Metab       Date:  2017-11-09       Impact factor: 27.287

4.  Generation of Tumor Antigen-Specific iPSC-Derived Thymic Emigrants Using a 3D Thymic Culture System.

Authors:  Raul Vizcardo; Nicholas D Klemen; S M Rafiqul Islam; Devikala Gurusamy; Naritaka Tamaoki; Daisuke Yamada; Haruhiko Koseki; Benjamin L Kidder; Zhiya Yu; Li Jia; Amanda N Henning; Meghan L Good; Marta Bosch-Marce; Takuya Maeda; Chengyu Liu; Zied Abdullaev; Svetlana Pack; Douglas C Palmer; David F Stroncek; Fumito Ito; Francis A Flomerfelt; Michael J Kruhlak; Nicholas P Restifo
Journal:  Cell Rep       Date:  2018-03-20       Impact factor: 9.423

5.  Optimization of cGMP purification and expansion of umbilical cord blood-derived T-regulatory cells in support of first-in-human clinical trials.

Authors:  David H McKenna; Darin Sumstad; Diane M Kadidlo; Bjorn Batdorf; Colin J Lord; Sarah C Merkel; Christine M Koellner; Julie M Curtsinger; Carl H June; James L Riley; Bruce L Levine; Jeffrey S Miller; Claudio G Brunstein; John E Wagner; Bruce R Blazar; Keli L Hippen
Journal:  Cytotherapy       Date:  2016-11-22       Impact factor: 5.414

6.  Prospects for gene-engineered T cell immunotherapy for solid cancers.

Authors:  Christopher A Klebanoff; Steven A Rosenberg; Nicholas P Restifo
Journal:  Nat Med       Date:  2016-01       Impact factor: 53.440

Review 7.  Improving therapy of chronic lymphocytic leukemia with chimeric antigen receptor T cells.

Authors:  Joseph A Fraietta; Robert D Schwab; Marcela V Maus
Journal:  Semin Oncol       Date:  2016-02-09       Impact factor: 4.929

Review 8.  Neoantigen Specific T Cells Derived From T Cell-Derived Induced Pluripotent Stem Cells for the Treatment of Hepatocellular Carcinoma: Potential and Challenges.

Authors:  Fei Lu; Xiao-Jing-Nan Ma; Wei-Lin Jin; Yang Luo; Xun Li
Journal:  Front Immunol       Date:  2021-05-13       Impact factor: 7.561

9.  First-in-human phase 1 trial of induced regulatory T cells for graft-versus-host disease prophylaxis in HLA-matched siblings.

Authors:  Margaret L MacMillan; Keli L Hippen; David H McKenna; Diane Kadidlo; Darin Sumstad; Todd E DeFor; Claudio G Brunstein; Shernan G Holtan; Jeffrey S Miller; Erica D Warlick; Daniel J Weisdorf; John E Wagner; Bruce R Blazar
Journal:  Blood Adv       Date:  2021-03-09

Review 10.  Epigenetic control of CD8+ T cell differentiation.

Authors:  Amanda N Henning; Rahul Roychoudhuri; Nicholas P Restifo
Journal:  Nat Rev Immunol       Date:  2018-01-30       Impact factor: 53.106
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.